Cục Thông tin khoa học và công nghệ quốc gia trân trọng kính gửi đến các nhà khoa học những xu hướng nghiên cứu và nhận định về vắc-xin COVID-19 hiện nay trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài. 

PUBMED

1. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.

Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N.

Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.

PMID: 34715347

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548286/pdf/main.pdf

2. Omicron variant and booster COVID-19 vaccines.

Burki TK.

Lancet Respir Med. 2022 Feb;10(2):e17. doi: 10.1016/S2213-2600(21)00559-2. Epub 2021 Dec 17.

PMID: 34929158

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683118/pdf/main.pdf

3. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.

Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W.

Int J Infect Dis. 2022 Jan;114:252-260. doi: 10.1016/j.ijid.2021.11.009. Epub 2021 Nov 17.

PMID: 34800687

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595975/pdf/main.pdf

4. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.

Zinatizadeh MR, Zarandi PK, Zinatizadeh M, Yousefi MH, Amani J, Rezaei N.

Biomed Pharmacother. 2022 Feb;146:112527. doi: 10.1016/j.biopha.2021.112527. Epub 2021 Dec 10.

PMID: 34906769

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660177/pdf/main.pdf

5. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities.

Govender K, Nyamaruze P, McKerrow N, Meyer-Weitz A, Cowden RG.

BMJ Glob Health. 2022 Feb;7(2):e007839. doi: 10.1136/bmjgh-2021-007839.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844950/pdf/bmjgh-2021-007839.pdf

6. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.

Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, Nehlmeier I, Graichen L, Moldenhauer AS, Winkler MS, Lier M, Dopfer-Jablonka A, Jäck HM, Behrens GMN, Pöhlmann S.

Cell. 2022 Feb 3;185(3):447-456.e11. doi: 10.1016/j.cell.2021.12.032. Epub 2021 Dec 24.

PMID: 35026151 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702401/pdf/main.pdf

7. Innovations and development of Covid-19 vaccines: A patent review.

Alshrari AS, Hudu SA, Imran M, Asdaq SMB, Ali AM, Rabbani SI.

J Infect Public Health. 2022 Jan;15(1):123-131. doi: 10.1016/j.jiph.2021.10.021. Epub 2021 Oct 23.

PMID: 34742639

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539827/pdf/main.pdf

8. Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.

Tande AJ, Pollock BD, Shah ND, Farrugia G, Virk A, Swift M, Breeher L, Binnicker M, Berbari EF.

Clin Infect Dis. 2022 Jan 7;74(1):59-65. doi: 10.1093/cid/ciab229.

PMID: 33704435 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989519/pdf/ciab229.pdf

9. Covid-19 Vaccine Effectiveness in New York State.

Rosenberg ES, Dorabawila V, Easton D, Bauer UE, Kumar J, Hoen R, Hoefer D, Wu M, Lutterloh E, Conroy MB, Greene D, Zucker HA.

N Engl J Med. 2022 Jan 13;386(2):116-127. doi: 10.1056/NEJMoa2116063. Epub 2021 Dec 1.

PMID: 34942067 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693697/pdf/NEJMoa2116063.pdf

10. COVID-19 vaccines and skin manifestations.

Bataille V, Puig S.

Br J Dermatol. 2022 Jan;186(1):15. doi: 10.1111/bjd.20807. Epub 2021 Nov 2.

PMID: 34726781

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653104/pdf/BJD-9999-0.pdf

11. COVID-19 vaccination for children with cancer.

Kotecha RS.

Pediatr Blood Cancer. 2022 Feb;69(2):e29340. doi: 10.1002/pbc.29340. Epub 2021 Sep 14.

PMID: 34519421

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662031/pdf/PBC-9999-0.pdf

12. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.

Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH.

J Cutan Pathol. 2022 Jan;49(1):34-41. doi: 10.1111/cup.14104. Epub 2021 Aug 8.

PMID: 34292611 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444807/pdf/CUP-9999-0.pdf

SCIENCEDIRECT

1. Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2

Journal of Molecular Structure, 13 August 2021, Volume 1247 (Cover date: 5 January 2022), Article 131296

Haroon ur Rashid, Nasir Ahmad, Samah Shabana

https://www.sciencedirect.com/science/article/pii/S0022286021014253/pdfft?md5=0ff45dde50eeefff3a8a57fca582091c&pid=1-s2.0-S0022286021014253-main.pdf

2. Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies

Saudi Journal of Biological Sciences, 17 September 2021, Volume 29, Issue 1 (Cover date: January 2022), Pages 526-533

Alhumaidi B. Alabbas, Mubarak A. Alamri

https://www.sciencedirect.com/science/article/pii/S1319562X21008299/pdfft?md5=4ef1daad9e159c27356b952be642719e&pid=1-s2.0-S1319562X21008299-main.pdf

3. On the deformation and frequency analyses of SARS-CoV-2 at nanoscale

International Journal of Engineering Science, 29 October 2021, Volume 170 (Cover date: 1 January 2022), Article 103604

Shahriar Dastjerdi, Mohammad Malikan, Victor A. Eremeyev

https://www.sciencedirect.com/science/article/pii/S0020722521001440/pdfft?md5=afb1f2b98782be6d048d075b82f4dcf2&pid=1-s2.0-S0020722521001440-main.pdf

4. Paper-based immunoassay based on 96-well wax-printed paper plate combined with magnetic beads and colorimetric smartphone-assisted measure for reliable detection of SARS-CoV-2 in saliva

Biosensors and Bioelectronics, 23 December 2021, Volume 200 (Cover date: 15 March 2022), Article 113909

Laura Fabiani, Vincenzo Mazzaracchio, Fabiana Arduini

https://www.sciencedirect.com/science/article/pii/S0956566321009465/pdfft?md5=6180390bbaac7613b1ff96bc10dd3de8&pid=1-s2.0-S0956566321009465-main.pdf

5. Synthesis and investigation of anti-COVID19 ability of ferrocene Schiff base derivatives by quantum chemical and molecular docking

Journal of Molecular Structure, 24 December 2021, Volume 1253 (Cover date: 5 April 2022), Article 132242

Ghulam Abbas, Ahmad Irfan, Renjith Thomas

https://www.sciencedirect.com/science/article/pii/S0022286021023620/pdfft?md5=aad361e9e957b2adb7de789491520c5c&pid=1-s2.0-S0022286021023620-main.pdf

6. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020

International Journal of Infectious Diseases, 12 October 2021, Volume 114 (Cover date: January 2022), Pages 21-28

Kevin B. Spicer, Connor Glick, Douglas Thoroughman

https://www.sciencedirect.com/science/article/pii/S1201971221008006/pdfft?md5=782d98aca4e04c3a8fea0e5cdca480e6&pid=1-s2.0-S1201971221008006-main.pdf

7. Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition

Journal of Molecular Graphics and Modelling, 11 October 2021, Volume 110 (Cover date: January 2022), Article 108050

Julia Liang, Eleni Pitsillou, Tom C. Karagiannis

https://www.sciencedirect.com/science/article/pii/S1093326321002217/pdfft?md5=d2b763da9bdd3f447a56d1298723232f&pid=1-s2.0-S1093326321002217-main.pdf

8. In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

Journal of Ayurveda and Integrative Medicine, 25 February 2021, Volume 13, Issue 1 (Cover date: January-March 2022), Article 100413

Thrigulla Saketh Ram, Manne Munikumar, K. S. Dhiman

https://www.sciencedirect.com/science/article/pii/S097594762100019X/pdfft?md5=8a07a7e7d7fd4429d8c9f8a4e0b43ab9&pid=1-s2.0-S097594762100019X-main.pdf

9. SPEEDS: A portable serological testing platform for rapid electrochemical detection of SARS-CoV-2 antibodies

Biosensors and Bioelectronics, 1 November 2021, Volume 197 (Cover date: 1 February 2022), Article 113762

Ran Peng, Yueyue Pan, Xinyu Liu

https://www.sciencedirect.com/science/article/pii/S0956566321007995/pdfft?md5=441cc385f8e93b4125feda2ef6a81b3e&pid=1-s2.0-S0956566321007995-main.pdf

10. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice

eBioMedicine, 31 December 2021, Volume 75 (Cover date: January 2022), Article 103803

Jianxiong Zeng, Xiaochun Xie, Yong-Gang Yao

https://www.sciencedirect.com/science/article/pii/S2352396421005971/pdfft?md5=789a5657f59459aae20424d11addeac9&pid=1-s2.0-S2352396421005971-main.pdf

11. Anticipating hopes, fears and expectations towards COVID-19 vaccines: A qualitative interview study in seven European countries

SSM - Qualitative Research in Health, 4 January 2022, Volume 2 (Cover date: December 2022), Article 100035

Katharina T. Paul, Bettina M. Zimmermann, Ine Van Hoyweghen

https://www.sciencedirect.com/science/article/pii/S2667321521000354/pdfft?md5=dcdb7d3ae567db189dd9f8be75f7a700&pid=1-s2.0-S2667321521000354-main.pdf

12. Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK

The Lancet Regional Health - Europe, 3 February 2022, Volume 14 (Cover date: March 2022), Article 100317

Elise Paul, Daisy Fancourt

https://www.sciencedirect.com/science/article/pii/S2666776222000102/pdfft?md5=910df5c0b1317fa83dc31be9a2c95cfe&pid=1-s2.0-S2666776222000102-main.pdf

13. Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities

Vaccine, 27 December 2021, Volume 40, Issue 5 (Cover date: 31 January 2022), Pages 734-741

Samta Shukla, Francois Fressin, Sreekanth K. Chaguturu

https://www.sciencedirect.com/science/article/pii/S0264410X21016571/pdfft?md5=33339323919ae549cdbef496c98e709b&pid=1-s2.0-S0264410X21016571-main.pdf

14. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

Clinical Microbiology and Infection, 5 October 2021, Volume 28, Issue 2 (Cover date: February 2022), Pages 279-284

Eliseo Albert, Javier S. Burgos, David Navarro

https://www.sciencedirect.com/science/article/pii/S1198743X21005607/pdfft?md5=86eedbffdd2b79c1e8f6acbcb58ce863&pid=1-s2.0-S1198743X21005607-main.pdf

15. COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes

Vaccine, 17 January 2022, Volume 40, Issue 7 (Cover date: 11 February 2022), Pages 970-976

Leàn Rolfes, Linda Härmark, Florence van Hunsel

https://www.sciencedirect.com/science/article/pii/S0264410X22000287/pdfft?md5=3bb65bbf2c3a0af3f6d633e9cd06ae43&pid=1-s2.0-S0264410X22000287-main.pdf

16. Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines

Medical Hypotheses, 3 January 2022, Volume 159 (Cover date: February 2022), Article 110756

Peter A. Feldman

https://www.sciencedirect.com/science/article/pii/S0306987721002759/pdfft?md5=45171c8205e827f11d903c76a3587fb1&pid=1-s2.0-S0306987721002759-main.pdf

17. Cov19VaxKB: A web-based integrative COVID-19 vaccine knowledge base

Vaccine: X, 28 December 2021, Volume 10 (Cover date: April 2022), Article 100139

Philip C. Huang, Rohit Goru, Yongqun He

https://www.sciencedirect.com/science/article/pii/S2590136221000565/pdfft?md5=3f739419f93b76ce6c7980e83463fceb&pid=1-s2.0-S2590136221000565-main.pdf

18. Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England

The Lancet Regional Health - Europe, 13 December 2021, Volume 13 (Cover date: February 2022), Article 100260

Nick J Andrews, Julia Stowe, Elizabeth Miller

https://www.sciencedirect.com/science/article/pii/S2666776221002465/pdfft?md5=6e2dc644f4da9eca36e8d28a88e93ae9&pid=1-s2.0-S2666776221002465-main.pdf

19. Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation

Vaccine, 16 December 2021, Volume 40, Issue 4 (Cover date: 28 January 2022), Pages 594-600

Samantha J. Carlson, Lara McKenzie, Katie Attwell

https://www.sciencedirect.com/science/article/pii/S0264410X21016297/pdfft?md5=555f92a204c7cbe0650256fd44e60d20&pid=1-s2.0-S0264410X21016297-main.pdf

20. COVID-19 vaccine acceptance in South Asia: a multi-country study

International Journal of Infectious Diseases, 28 September 2021, Volume 114 (Cover date: January 2022), Pages 1-10

Mohammad Delwer Hossain Hawlader, Mohammad Lutfor Rahman, Mohammad Hayatun Nabi

https://www.sciencedirect.com/science/article/pii/S1201971221007591/pdfft?md5=3ce84430f299412251af184b6f407803&pid=1-s2.0-S1201971221007591-main.pdf

SPRINGER NATURE

1. Covid-19-vaccine-pfizer-biontech

Reactions Weekly (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40278-022-07895-x.pdf

2. A review of the safety and efficacy of current COVID-19 vaccines

Zehong Huang, Yingying Su, Tianying Zhang, Ningshao Xia in Frontiers of Medicine (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11684-021-0893-y.pdf

3. Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study

Philippe Hanna, Aline Issa, Ziad Noujeim… in Journal of Pharmaceutical Policy and Pract… (2022)

https://link.springer.com/content/pdf/10.1186%2Fs40545-021-00403-x.pdf

4. Coronavirus Disease 2019 (COVID-19) Vaccination for Children: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices

Dr Srinivas G. Kasi, Shashi Kant Dhir, Abhay Shah, S. Shivananda… in Indian Pediatrics (2022)

https://link.springer.com/content/pdf/10.1007%2Fs13312-022-2421-9.pdf

5. Correction to: Optimal control analysis of COVID-19 vaccine epidemic model: a case study

Arshad Alam Khan, Saif Ullah, Rohul Amin in The European Physical Journal Plus (2022)

https://link.springer.com/content/pdf/10.1140%2Fepjp%2Fs13360-022-02420-4.pdf

6. Covid-19-vaccine/influenza-virus-vaccine

Reactions Weekly (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40278-022-08484-3.pdf

7. Insights on Epidemiology, Pathogenesis, Diagnosis and Possible Treatment of COVID-19 Infection

Shashank Kumar Maurya, Amit Bhattacharya… in Proceedings of the National Academy of Sci… (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40011-021-01319-x.pdf

8. Spectrum of neurological complications following COVID-19 vaccination

Ravindra Kumar Garg, Vimal Kumar Paliwal in Neurological Sciences (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10072-021-05662-9.pdf

9.  Practice report: an Alberta Métis model for COVID-19 vaccine delivery

Keith D. King, Reagan Bartel, Ashton James… in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-021-00603-7.pdf

10. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia

Metadel Adane, Ayechew Ademas, Helmut Kloos in BMC Public Health (2022)

https://link.springer.com/content/pdf/10.1186%2Fs12889-021-12362-8.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 11/02 đến ngày 18/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/covid-19-va-nhung-tac-dong-doi-voi-doi-song-ngay-11-18-2-2022-4685.html

Cập nhật các công bố về COVID-19 từ ngày 04/02 đến ngày 11/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-covid-19-tu-ngay-4-2-den-ngay-11-2-2022-4664.html

Cập nhật các công bố về COVID-19 từ ngày 21/01 đến ngày 28/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-21-01-den-ngay-28-01-2022-4639.html

Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-14-1-den-ngay-21-1-2022-4618.html

Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-7-1-den-ngay-14-1-2022-4601.html

Cập nhật các công bố về COVID-19 từ ngày 01/01 đến ngày 7/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-3-1-den-ngay-7-1-2022-4584.html

Nguồn: Cục Thông tin khoa học và công nghệ quốc gia, 25/2/2022

Cục Thông tin khoa học và công nghệ quốc gia trân trọng kính gửi đến các nhà khoa học những xu hướng nghiên cứu và nhận định về vắc-xin COVID-19 hiện nay trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài. 

PUBMED

1. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.

Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N.

Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.

PMID: 34715347

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548286/pdf/main.pdf

2. Omicron variant and booster COVID-19 vaccines.

Burki TK.

Lancet Respir Med. 2022 Feb;10(2):e17. doi: 10.1016/S2213-2600(21)00559-2. Epub 2021 Dec 17.

PMID: 34929158

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683118/pdf/main.pdf

3. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.

Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W.

Int J Infect Dis. 2022 Jan;114:252-260. doi: 10.1016/j.ijid.2021.11.009. Epub 2021 Nov 17.

PMID: 34800687

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595975/pdf/main.pdf

4. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.

Zinatizadeh MR, Zarandi PK, Zinatizadeh M, Yousefi MH, Amani J, Rezaei N.

Biomed Pharmacother. 2022 Feb;146:112527. doi: 10.1016/j.biopha.2021.112527. Epub 2021 Dec 10.

PMID: 34906769

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660177/pdf/main.pdf

5. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities.

Govender K, Nyamaruze P, McKerrow N, Meyer-Weitz A, Cowden RG.

BMJ Glob Health. 2022 Feb;7(2):e007839. doi: 10.1136/bmjgh-2021-007839.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844950/pdf/bmjgh-2021-007839.pdf

6. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.

Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, Nehlmeier I, Graichen L, Moldenhauer AS, Winkler MS, Lier M, Dopfer-Jablonka A, Jäck HM, Behrens GMN, Pöhlmann S.

Cell. 2022 Feb 3;185(3):447-456.e11. doi: 10.1016/j.cell.2021.12.032. Epub 2021 Dec 24.

PMID: 35026151 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702401/pdf/main.pdf

7. Innovations and development of Covid-19 vaccines: A patent review.

Alshrari AS, Hudu SA, Imran M, Asdaq SMB, Ali AM, Rabbani SI.

J Infect Public Health. 2022 Jan;15(1):123-131. doi: 10.1016/j.jiph.2021.10.021. Epub 2021 Oct 23.

PMID: 34742639

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539827/pdf/main.pdf

8. Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.

Tande AJ, Pollock BD, Shah ND, Farrugia G, Virk A, Swift M, Breeher L, Binnicker M, Berbari EF.

Clin Infect Dis. 2022 Jan 7;74(1):59-65. doi: 10.1093/cid/ciab229.

PMID: 33704435 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989519/pdf/ciab229.pdf

9. Covid-19 Vaccine Effectiveness in New York State.

Rosenberg ES, Dorabawila V, Easton D, Bauer UE, Kumar J, Hoen R, Hoefer D, Wu M, Lutterloh E, Conroy MB, Greene D, Zucker HA.

N Engl J Med. 2022 Jan 13;386(2):116-127. doi: 10.1056/NEJMoa2116063. Epub 2021 Dec 1.

PMID: 34942067 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693697/pdf/NEJMoa2116063.pdf

10. COVID-19 vaccines and skin manifestations.

Bataille V, Puig S.

Br J Dermatol. 2022 Jan;186(1):15. doi: 10.1111/bjd.20807. Epub 2021 Nov 2.

PMID: 34726781

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653104/pdf/BJD-9999-0.pdf

11. COVID-19 vaccination for children with cancer.

Kotecha RS.

Pediatr Blood Cancer. 2022 Feb;69(2):e29340. doi: 10.1002/pbc.29340. Epub 2021 Sep 14.

PMID: 34519421

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662031/pdf/PBC-9999-0.pdf

12. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.

Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH.

J Cutan Pathol. 2022 Jan;49(1):34-41. doi: 10.1111/cup.14104. Epub 2021 Aug 8.

PMID: 34292611 Free PMC article.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444807/pdf/CUP-9999-0.pdf

SCIENCEDIRECT

1. Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2

Journal of Molecular Structure, 13 August 2021, Volume 1247 (Cover date: 5 January 2022), Article 131296

Haroon ur Rashid, Nasir Ahmad, Samah Shabana

https://www.sciencedirect.com/science/article/pii/S0022286021014253/pdfft?md5=0ff45dde50eeefff3a8a57fca582091c&pid=1-s2.0-S0022286021014253-main.pdf

2. Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies

Saudi Journal of Biological Sciences, 17 September 2021, Volume 29, Issue 1 (Cover date: January 2022), Pages 526-533

Alhumaidi B. Alabbas, Mubarak A. Alamri

https://www.sciencedirect.com/science/article/pii/S1319562X21008299/pdfft?md5=4ef1daad9e159c27356b952be642719e&pid=1-s2.0-S1319562X21008299-main.pdf

3. On the deformation and frequency analyses of SARS-CoV-2 at nanoscale

International Journal of Engineering Science, 29 October 2021, Volume 170 (Cover date: 1 January 2022), Article 103604

Shahriar Dastjerdi, Mohammad Malikan, Victor A. Eremeyev

https://www.sciencedirect.com/science/article/pii/S0020722521001440/pdfft?md5=afb1f2b98782be6d048d075b82f4dcf2&pid=1-s2.0-S0020722521001440-main.pdf

4. Paper-based immunoassay based on 96-well wax-printed paper plate combined with magnetic beads and colorimetric smartphone-assisted measure for reliable detection of SARS-CoV-2 in saliva

Biosensors and Bioelectronics, 23 December 2021, Volume 200 (Cover date: 15 March 2022), Article 113909

Laura Fabiani, Vincenzo Mazzaracchio, Fabiana Arduini

https://www.sciencedirect.com/science/article/pii/S0956566321009465/pdfft?md5=6180390bbaac7613b1ff96bc10dd3de8&pid=1-s2.0-S0956566321009465-main.pdf

5. Synthesis and investigation of anti-COVID19 ability of ferrocene Schiff base derivatives by quantum chemical and molecular docking

Journal of Molecular Structure, 24 December 2021, Volume 1253 (Cover date: 5 April 2022), Article 132242

Ghulam Abbas, Ahmad Irfan, Renjith Thomas

https://www.sciencedirect.com/science/article/pii/S0022286021023620/pdfft?md5=aad361e9e957b2adb7de789491520c5c&pid=1-s2.0-S0022286021023620-main.pdf

6. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020

International Journal of Infectious Diseases, 12 October 2021, Volume 114 (Cover date: January 2022), Pages 21-28

Kevin B. Spicer, Connor Glick, Douglas Thoroughman

https://www.sciencedirect.com/science/article/pii/S1201971221008006/pdfft?md5=782d98aca4e04c3a8fea0e5cdca480e6&pid=1-s2.0-S1201971221008006-main.pdf

7. Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition

Journal of Molecular Graphics and Modelling, 11 October 2021, Volume 110 (Cover date: January 2022), Article 108050

Julia Liang, Eleni Pitsillou, Tom C. Karagiannis

https://www.sciencedirect.com/science/article/pii/S1093326321002217/pdfft?md5=d2b763da9bdd3f447a56d1298723232f&pid=1-s2.0-S1093326321002217-main.pdf

8. In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

Journal of Ayurveda and Integrative Medicine, 25 February 2021, Volume 13, Issue 1 (Cover date: January-March 2022), Article 100413

Thrigulla Saketh Ram, Manne Munikumar, K. S. Dhiman

https://www.sciencedirect.com/science/article/pii/S097594762100019X/pdfft?md5=8a07a7e7d7fd4429d8c9f8a4e0b43ab9&pid=1-s2.0-S097594762100019X-main.pdf

9. SPEEDS: A portable serological testing platform for rapid electrochemical detection of SARS-CoV-2 antibodies

Biosensors and Bioelectronics, 1 November 2021, Volume 197 (Cover date: 1 February 2022), Article 113762

Ran Peng, Yueyue Pan, Xinyu Liu

https://www.sciencedirect.com/science/article/pii/S0956566321007995/pdfft?md5=441cc385f8e93b4125feda2ef6a81b3e&pid=1-s2.0-S0956566321007995-main.pdf

10. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice

eBioMedicine, 31 December 2021, Volume 75 (Cover date: January 2022), Article 103803

Jianxiong Zeng, Xiaochun Xie, Yong-Gang Yao

https://www.sciencedirect.com/science/article/pii/S2352396421005971/pdfft?md5=789a5657f59459aae20424d11addeac9&pid=1-s2.0-S2352396421005971-main.pdf

11. Anticipating hopes, fears and expectations towards COVID-19 vaccines: A qualitative interview study in seven European countries

SSM - Qualitative Research in Health, 4 January 2022, Volume 2 (Cover date: December 2022), Article 100035

Katharina T. Paul, Bettina M. Zimmermann, Ine Van Hoyweghen

https://www.sciencedirect.com/science/article/pii/S2667321521000354/pdfft?md5=dcdb7d3ae567db189dd9f8be75f7a700&pid=1-s2.0-S2667321521000354-main.pdf

12. Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK

The Lancet Regional Health - Europe, 3 February 2022, Volume 14 (Cover date: March 2022), Article 100317

Elise Paul, Daisy Fancourt

https://www.sciencedirect.com/science/article/pii/S2666776222000102/pdfft?md5=910df5c0b1317fa83dc31be9a2c95cfe&pid=1-s2.0-S2666776222000102-main.pdf

13. Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities

Vaccine, 27 December 2021, Volume 40, Issue 5 (Cover date: 31 January 2022), Pages 734-741

Samta Shukla, Francois Fressin, Sreekanth K. Chaguturu

https://www.sciencedirect.com/science/article/pii/S0264410X21016571/pdfft?md5=33339323919ae549cdbef496c98e709b&pid=1-s2.0-S0264410X21016571-main.pdf

14. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

Clinical Microbiology and Infection, 5 October 2021, Volume 28, Issue 2 (Cover date: February 2022), Pages 279-284

Eliseo Albert, Javier S. Burgos, David Navarro

https://www.sciencedirect.com/science/article/pii/S1198743X21005607/pdfft?md5=86eedbffdd2b79c1e8f6acbcb58ce863&pid=1-s2.0-S1198743X21005607-main.pdf

15. COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes

Vaccine, 17 January 2022, Volume 40, Issue 7 (Cover date: 11 February 2022), Pages 970-976

Leàn Rolfes, Linda Härmark, Florence van Hunsel

https://www.sciencedirect.com/science/article/pii/S0264410X22000287/pdfft?md5=3bb65bbf2c3a0af3f6d633e9cd06ae43&pid=1-s2.0-S0264410X22000287-main.pdf

16. Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines

Medical Hypotheses, 3 January 2022, Volume 159 (Cover date: February 2022), Article 110756

Peter A. Feldman

https://www.sciencedirect.com/science/article/pii/S0306987721002759/pdfft?md5=45171c8205e827f11d903c76a3587fb1&pid=1-s2.0-S0306987721002759-main.pdf

17. Cov19VaxKB: A web-based integrative COVID-19 vaccine knowledge base

Vaccine: X, 28 December 2021, Volume 10 (Cover date: April 2022), Article 100139

Philip C. Huang, Rohit Goru, Yongqun He

https://www.sciencedirect.com/science/article/pii/S2590136221000565/pdfft?md5=3f739419f93b76ce6c7980e83463fceb&pid=1-s2.0-S2590136221000565-main.pdf

18. Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England

The Lancet Regional Health - Europe, 13 December 2021, Volume 13 (Cover date: February 2022), Article 100260

Nick J Andrews, Julia Stowe, Elizabeth Miller

https://www.sciencedirect.com/science/article/pii/S2666776221002465/pdfft?md5=6e2dc644f4da9eca36e8d28a88e93ae9&pid=1-s2.0-S2666776221002465-main.pdf

19. Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation

Vaccine, 16 December 2021, Volume 40, Issue 4 (Cover date: 28 January 2022), Pages 594-600

Samantha J. Carlson, Lara McKenzie, Katie Attwell

https://www.sciencedirect.com/science/article/pii/S0264410X21016297/pdfft?md5=555f92a204c7cbe0650256fd44e60d20&pid=1-s2.0-S0264410X21016297-main.pdf

20. COVID-19 vaccine acceptance in South Asia: a multi-country study

International Journal of Infectious Diseases, 28 September 2021, Volume 114 (Cover date: January 2022), Pages 1-10

Mohammad Delwer Hossain Hawlader, Mohammad Lutfor Rahman, Mohammad Hayatun Nabi

https://www.sciencedirect.com/science/article/pii/S1201971221007591/pdfft?md5=3ce84430f299412251af184b6f407803&pid=1-s2.0-S1201971221007591-main.pdf

SPRINGER NATURE

1. Covid-19-vaccine-pfizer-biontech

Reactions Weekly (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40278-022-07895-x.pdf

2. A review of the safety and efficacy of current COVID-19 vaccines

Zehong Huang, Yingying Su, Tianying Zhang, Ningshao Xia in Frontiers of Medicine (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11684-021-0893-y.pdf

3. Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study

Philippe Hanna, Aline Issa, Ziad Noujeim… in Journal of Pharmaceutical Policy and Pract… (2022)

https://link.springer.com/content/pdf/10.1186%2Fs40545-021-00403-x.pdf

4. Coronavirus Disease 2019 (COVID-19) Vaccination for Children: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices

Dr Srinivas G. Kasi, Shashi Kant Dhir, Abhay Shah, S. Shivananda… in Indian Pediatrics (2022)

https://link.springer.com/content/pdf/10.1007%2Fs13312-022-2421-9.pdf

5. Correction to: Optimal control analysis of COVID-19 vaccine epidemic model: a case study

Arshad Alam Khan, Saif Ullah, Rohul Amin in The European Physical Journal Plus (2022)

https://link.springer.com/content/pdf/10.1140%2Fepjp%2Fs13360-022-02420-4.pdf

6. Covid-19-vaccine/influenza-virus-vaccine

Reactions Weekly (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40278-022-08484-3.pdf

7. Insights on Epidemiology, Pathogenesis, Diagnosis and Possible Treatment of COVID-19 Infection

Shashank Kumar Maurya, Amit Bhattacharya… in Proceedings of the National Academy of Sci… (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40011-021-01319-x.pdf

8. Spectrum of neurological complications following COVID-19 vaccination

Ravindra Kumar Garg, Vimal Kumar Paliwal in Neurological Sciences (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10072-021-05662-9.pdf

9.  Practice report: an Alberta Métis model for COVID-19 vaccine delivery

Keith D. King, Reagan Bartel, Ashton James… in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-021-00603-7.pdf

10. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia

Metadel Adane, Ayechew Ademas, Helmut Kloos in BMC Public Health (2022)

https://link.springer.com/content/pdf/10.1186%2Fs12889-021-12362-8.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 11/02 đến ngày 18/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/covid-19-va-nhung-tac-dong-doi-voi-doi-song-ngay-11-18-2-2022-4685.html

Cập nhật các công bố về COVID-19 từ ngày 04/02 đến ngày 11/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-covid-19-tu-ngay-4-2-den-ngay-11-2-2022-4664.html

Cập nhật các công bố về COVID-19 từ ngày 21/01 đến ngày 28/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-21-01-den-ngay-28-01-2022-4639.html

Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-14-1-den-ngay-21-1-2022-4618.html

Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-7-1-den-ngay-14-1-2022-4601.html

Cập nhật các công bố về COVID-19 từ ngày 01/01 đến ngày 7/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-3-1-den-ngay-7-1-2022-4584.html

Nguồn: Cục Thông tin khoa học và công nghệ quốc gia, 25/2/2022